Jaguar Health, Inc.
About
3.55USD+0.26 +7.90%
Closed • Updated at 06:57 GMT+00:00Market Cap$2.14M
Volume69.2K
Beta1.91
RSI31.58
Gross Margin77.69%
Jaguar Health, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 28 2026
Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
May 27 2026
Jaguar Health Compliant with Nasdaq Bid Price Rule
May 20 2026
Jaguar Health Reports First Quarter 2026 Financials
May 20 2026
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference
May 19 2026
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
Community Chat
Ask AI
Try asking